NCT01632436 2023-10-02
Hepatic
CTI BioPharma
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT01491841 2020-03-04
BRP
Duke University
Phase 1 Completed
NCT02800889 2020-01-29
Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
CTI BioPharma
Phase 1 Withdrawn
NCT00060684 2015-01-19
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma
CTI BioPharma
Phase 1 Completed